In today’s recent session, 1.07 million shares of the Atyr Pharma Inc (NASDAQ:ATYR) have been traded, and its beta is 0.89. Most recently the company’s share price was $5.18, and it changed around -$0.3 or -5.47% from the last close, which brings the market valuation of the company to $461.04M. ATYR at last check was trading at a discount to its 52-week high of $5.98, offering almost -15.44% off that amount. The share price’s 52-week low was $1.42, which indicates that the recent value has risen by an impressive 72.59% since then.

Atyr Pharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended ATYR as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Instantly ATYR has been showing red trend so far today with a performance of -5.47% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.75 on recent trading dayincreased the stock’s daily price by 9.91%. The company’s shares are currently up 43.09% year-to-date, but still down -5.82% over the last five days. On the other hand, Atyr Pharma Inc (NASDAQ:ATYR) is 58.41% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.28%.

ATYR Dividends

Atyr Pharma Inc’s next quarterly earnings report is expected to be released in July.